ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 26 filers reported holding ENLIVEX THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $64,000 | 0.09% |
| Lee Capital Holdings LLC | 11,805 | $50,000 | 0.07% |
| Susquehanna International Group Ltd. | 20,299 | $85,000 | 0.03% |
| Compagnie Lombard Odier SCmA | 50,000 | $211,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $55,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 750 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 18,054 | $77,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 484 | $2,000 | 0.00% |